BSEResult4d ago · 14 Nov 2026, 05:31 pm

Dear Sir/Ma''am, Please find Unaudited Financial Results for the Quarter and Half year ended 30.09.2026

Omkar Pharmachem Ltd · 532167

✦ AI SummaryResults

Omkar Pharmachem Ltd has released unaudited financial results for the quarter and half year ended 30th September, 2026. The results show a net profit of Rs. 0.39 lakhs for the quarter and Rs. 7.74 lakhs for the half year. The company's total assets stood at Rs. 3667.59 lakhs as of 30th September, 2026, with total equity at Rs. 3663.36 lakhs. The company's cash and cash equivalents stood at Rs. 16.47 lakhs as of 30th September, 2026.

Analysis Scores

Earnings Impact2/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Omkar Pharmachem Ltd - 532167 - Unaudited Financial Results Of The Company Along With Statement Of Assets And Liabilities, Cash Flow Statement And Limited Review Report For The Quarter And Half Year Ended On 30 September, 2026.

Attachments (1)

📄

3cf460c1-c45d-4adf-a702-1848e7a88007.pdf

pdf

Download →
View document text
39 Omkar Pharmachem L. Date: 14.11.2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Sub: - Unaudited Financial Result of the Company under Regulation 33 of the SEBI Listing Obligations And Disclosure Requirements) Regulations, 2015 for the Quarter and half vear ended on 30" September, 2026 Company Serip Code: 532167 Dear Sir(s). Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please find enclosed herewith: Unaudited Financial Results of the Company along with Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report for the Quarter and half year ended on 30" September, 2026. The aforesaid result has been approved by the Board of Directors at their meeting held on 14" November, 2026. This is for your information and record. Thanking You, Yours faithfully, For Omkar Pharmachem Limited Bhawani S Goyal (Managing Director) DIN: 03255804 Address: Ward No-03, Nangal Chaudhry, Narnaul, Mahendragarh, Haryana-123023 Encl: a/a Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163 CIN: L93000GJ1995PLC025276, Email: investors.opl@gmail.com, Website: www.omkarpharmachem.co.in | :':;’o Ombkar Pharmachem LeD. Statement of Standalone Unaudited Financial Results for the Quarter and Six Months ended 30th September, 2026 (Rs. in lakhs except per sharc data) Sr. Quarter Ended On Six Months Ended On | Year Ended No Particulars On 30-09-2026 [30-06-2026 [30-09-2025 [30-09-2026 [30-09-2025 | 31-03-2026 (Unaudited)| (Unaudited) |(Unaudited)| (Unaudited) | (Unaudited)| (Audited) Part-l 1{Income from operations a)Net Sales/ Income from Operations 0.00 0.00 0.00 0.00 0.00 0.00 b)Other Operating Income 9.00 9.00 13.50! 18.00 27.00 46.50 9.00 9.00 13.50 18.00 27.00 46.50 2 |Other Income 0.00 0.00 0.44 0.00 0.44 0.74 3 |Net Total Income 9.00 9.00 13.94 18.00 27.44) 47.24 4 |Expenses a) Cost of material consumed 0.00 0.00 0.00 0.00 0.00 0.00 b) Purchase of Stock-in-trade 0.00 0.00 0.00 0.00 0.00 0.00 ¢) Changes in Inventories of Finished Goods, WIP and Stock-in trade 0.00 0.00 0.00 0.00 0.00 0.00 d) Employee benefits expenses 6.34 5.14 5.36 11.49 9.85 20.86 e) Finance Cost 0.00! 0.00 0.21 0.00 0.21 0.21 f) Depreciation and Amortization 0.03 0.04 0.08 0.07 0.16 0.33 2) Other Expenses 2.24 4.82 1.49 7.06 6.84 9.56 Total Expenses 8.61 10.00 7.14 18.62 17.06 30.96 5 |Profit(Loss) from operations before Exceptional Items & Taxes (3-4) 0.39 (1.00) 6.80 (0.62) 10.38 16.28 6 |Exceptional items: 0.00 0.00 0.00 0.00 0.00 0.00 7 |Profit(Loss) before Tax (5+6) 0.39 (1.00) 6.80 (0.62) 10.38 16.28 8 |Tax Expense 0.00 0.00 1.73 0.00 2.64 4.10 9 |Profit(Loss) for the period (7-8) 0.39 (1.00) 5.07 (0.62) 7.74 12.18 10 [Other Comprehensive Income 0.00 0.00 0.00 0.00 0.00 2708.43 11 |Total Comprehensive Income for the period (9+10) 0.39 (1.00) 5.07 (0.62) 7.74 272061 12 |Paid up Equity Share Capital (Face Value Rs. 10/-each) 1008.37] 1008.37 1008.37 1008.37 1008.37] 1008.37 13 |Other Equity N ) - . (52.82) 14 |Earning Per Share(before & after extraordinary items)(of Rs. 10 each)(not annualised) Basic and diluted Rs. 0.0039 (0.0099) 0.0503 (0.0061) 0.0768 0.1208 Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163 CIN: L93000GJ1995PLC025276, Email: investors.opl@gmail.com, Website: www.omkarpharmachem.co.in 39 Ombkar Phavmachem Le. Statement of Assets and Liabilities as at 30th September, 2026 (Rs. in lakhs) As at 30-09-2026 As a1 31-03-2026 Particulars (Unaudited) (Audited) ASSETS Non-current Assets a) Property, plant and equipment 0.30 037 b) Capital work-in-progress 0.00 0.00 ) Goodwill on consolidation 0.00 0.00 d) Other intangible assets 0.00 0.00] ¢) Intangible assets under development 0.00 0.00 ) Financial assets 0.00 0.00 i) Investments a) Investment in associate 0.00 0.00 b) Investments in joint ventures 0.00 0.00 ©) Other Investments 3638.43 363843 ii) Other Financial Assets 0.00 0.00| ) Deferred tax assets (net) 0.10 0.10] ) Other non current asscts 0.00 0.00 Total Non-current Asscts 3638.83 3638.90 Current Assets a) Inventories 0.00 0.00 b) Financial assets ) Other Investments 0.00 0.00 ii) Trade receivables 6.48 324 iii) Cash and cash equivalents 16.47 2173 iv) Bank balances other than iii) above 0.00 0.00/ V) Other financial assets 0.00 0.00 <) Other current assets 581 5.17 Total Current Assets 28.76 30.14, Total Assets 3667.59 3669.04 EQUITY AND LIABILITIES Equity ) Equity share capital 1008.37 1008.37 b) Other equity : Reserve and Surplus 2654.99 2655.61 Equity atiributable to the owners of the company 3663.36 366308 Non-controlling interests 0.00 0.00 Total Equity 3663.36 3663.98 Non-current liabilitics Financial liabilitics a) Borrowings 0.00 0.00 b) Provisions 0.00 0.00 ¢) Deferred tax liabilities(Net) 0.00 0.00 Total Non-current Linbilitics 0.00 0.00 Current Liabilities a) Financial liabilities i) Borrowings 0.00 0.00{ ii) Trade Payables 1.00 0.71 iii) Other fianncial liabilitics 0.00) 0.00 b) Provisions 0.00) 0.00 <) Other current liabilities 323 435 Total-current Liabilitics 423 5.06 Total Liabilitics 423 5.06 ‘Total Equity and Liabilities 3667.59 3669.04 Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163 : L93000GJ1985PLC025276, Email: investors opl@gmail com, Website: www.omkarpharmachem.co.in 39 Omkar Phavmachem Led. Unaudited Cash flow statement for the half year ended on 30th September, 2026 (Rs. in lakhs) Particulars Tall year ended THalf year ended 30th September, 2026 30th September, 2025 A. CASH FLOW FROM OPERATING ACTIVITIES Net profit before tax and exceptional items (0.62), 10.38 Adjustment For Depreciation 0.07 0.16 Net interest paid (received) 0.00 021 Operating profit before working capital change (0.55)| 10.75 Adjustment For Trade and other receivables (3.24), 0.00 Other current assets (0.64); 2.71) Trade and other payable 0.29 (0.23) Other current liabilities (1.12) (0.72) Cash Generated from operation (5.26)) 7.09 Cash flow before extra ordinary items 0.00 0.00 (Less) IncomeTaxPaid including AdvanceTax/TDS less refund 0.00 0.00 NET CASH FLOW FROM OPERATING ACTIVITIES (5.26) 7.09 B. CASH FLOW FROM INVESTING ACTIVITIES Sale of Property, plant and equipment (Land) 0.00 0.00 Sale of Investment 0.00 0.00 Purchase of Property, plant and equipment 0.00 0.00 NET CASH USED IN INVESTING ACTIVITIES 0.00 0.00 C. CASH FLOW FROM FINANCIAL ACTIVITIES Interest received/(paid) 0.00 021 Short Term Borrowings 0.00 (11.85) NET CASH FLOW FROM FINANCIAL ACTIVITIES 0.00 (12.06) TOTAL CASH FLOW (5.26) (4.97)] NET INCREASE/DECREASE IN CASH AND CASH EQUIVALENTS Opening Cash and Cash Equivalents 21.73 10.94 Closing Cash and Cash Equivalents 1647 597 NET INCREASE/DECREASE IN CASH AND CASH EQUIVALENTS (5.26) (4.97) Notes: 1. The above results have been reviewed by the Audit committee & approved by the Board of Directors at their respective meeting held on 14-11-2026 2. Corrasponding previous period figures are regrouped/rearranged whercever necessary, to make them comparable. 3. The Financial Result for the Quarter and Half year ended on 30-09-2026 has been prepared in accordance with IND-AS specified under section 133 oft he Companies Act and rules made thereunder. 4. The IND-AS regarding segment reporting is not applicable to the company. (Bhawani S Goyal) Managing Dircetor-. DIN No. 03255804 Date : 14-11-2026 | Ward No- 03, Nangal Chaudhry, Narnaul, Place: Ahmedabad I Mahendragarh, Haryana- 123023 Reg. Off.: 310, Wall Street-1, Near Gujarat College Cross Road, Ellisbridge Ahmedabad-380006, GJ, Ph.: 9711811163 CIN: L93000GJ1995PLC025276, Email: investors.opl@gmail.com, Website: www.omkarpharmachem co.in M‘|D RSC RELSE naco. 507, Mauryansh Elanza, Nr. Parekhs Hospital, Shyamal Cross Road, Road, Emall: info@drscindia.com TRUST | ETHICS| kNOWLEDGE Satdlite Anmadabad - 380 015. (M) 9 [Showing first 8,000 characters — download PDF for full document]